Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
SL Green Extends Loan on 1515 Broadway
-
Stock Yards Bancorp Declares Quarterly Cash Dividend of $0.31 Per Common Share
-
Aretec Wealth Inc. Partners with Advisor Solutions by Purpose for Advanced Independent Advisory Platform
-
Ocugen Announces European Medicines Agency Grants Orphan Medicinal Product Designation for Modifier Gene Therapy Candidate OCU410ST for Treatment of ABCA4-Associated Retinopathies including Stargardt
-
Dragonfly Energy Publishes 2023/2024 ESG Report Highlighting Commitment to a Sustainable Future and Diversity in its U.S. Workforce
-
Gulf Resources Provides Detailed Overview of the Economics of its Bromine Segment
-
Gulf Resources Announces Press Release Regarding Acquisition of Salt Fields
-
Ollie’s Bargain Outlet Holdings, Inc. Announces Third Quarter Fiscal 2024 Release Date and Conference Call Information
-
HydroGraph Receives Purchase Order for Four Novel Graphenes from Global Automotive Customer
-
23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Mirador’s Precision Medicines for Immunology & Inflammation
-
Form 8.3 - Learning Technologies Group Plc
-
TRYX Launches LUCA L70 in the EU: A Stylish Debut Redefining the DIY Experience
-
Organic Remedies Donates $20,000 to Support Pennsylvania Breast Cancer Survivors and Their Families
-
Alliance Witan PLC - Net Asset Value
-
Announcement of Extraordinary General Meeting Results
-
Scatec completes the Kalkbult, Linde, and Dreunberg transaction in South Africa
-
Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation from its ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer
-
Abcourt completes an induced polarization survey on its Flordin property between the Cartwright stripping and drilling completed in 2023
-
MADD Canada Partners with SGI and SLGA to Deliver Sober Driving Message to Saskatchewan Students
-
First Helium Reviewing Potential Follow Up Targets to Leduc Anomaly Drill
-
Willis Sustainable Fuels (UK) Limited Enters into Master Services Agreement with McDermott
-
Cartier Cuts High-Grade Intersection of 35.3 g/t Au over 4.4 m North of the Portal Zone on East Cadillac
-
Harfang Confirms and Expands High-Grade Gold Footprint at Serpent, Québec
-
LuxUrban Hotels Inc. Reports Third Quarter 2024 Financial Results
-
VitalHub announces SHREWD implementation with Winnipeg Regional Health Authority
-
Methode Electronics Appoints Lars Ullrich as Senior Vice President, Global Automotive Business
-
BioStem Technologies Signs Letter of Intent to Acquire Wound Care Products and Technologies from ProgenaCare Global
-
Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer’s Disease
-
Xtract One Announces Fiscal 2025 First Quarter Conference Call
-
Sol-Gel Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement
-
Update on Clinical Milestone - CytoMed Therapeutics Announces First Patient Dosed in its First-in-Human Phase I Clinical Trial of Allogeneic CAR-Gamma Delta T Cell Therapy in Patients with Advanced So
-
CONNEXA RECEIVES NASDAQ APPROVAL TO ACQUIRE YUANYU ENTERPRISE MANAGEMENT
-
NIP Group to Report Financial Results for the First Half of 2024 on November 25, 2024
-
RYVYL Amends MOU to Adjust Timing of First Tranche Payment to Investor to Retire 8% Senior Convertible Note and Series B Convertible Preferred Stock
-
Algorhythm Holdings Reports Third Quarter 2024 Results
-
Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery
-
PyroGenesis Anticipates Positive Economic Impact from Incoming Administration in the U.S.
-
Septerna Reports Third Quarter 2024 Financial Results and Recent Business Highlights
-
Solaris Announces Final Steps to Complete Emigration by Year-End, Including Management and Board Changes; Growth-Oriented Spin-out Anticipated in 2025
-
C4 Therapeutics Appoints Accomplished Oncology Executive Steve Hoerter to Board of Directors
-
Global-e Reports Third Quarter 2024 Results
-
NewAmsterdam Pharma Announces Positive Topline Data from Pivotal Phase 3 TANDEM Clinical Trial Evaluating the Fixed-Dose Combination of Obicetrapib 10 mg and Ezetimibe 10 mg in Patients with ASCVD or
-
OTC Markets Group Announces Launch of MOON ATS, A New Overnight Trading Platform for National Market System (NMS) Securities
-
FactSet Schedules First Quarter 2025 Earnings Call
-
Dataprana Confirms Intent to Co-Develop Its First AI Data Center in Texas
-
Worldline - Monthly information relating to the total number of voting rights and shares making up the share capital
-
OXB to host a free webinar on accelerating development of viral vectors through automated manufacturing and analytical development
-
Avextra Portugal Unveils Advanced Breeding Program to Develop Proprietary THC and CBD Cultivars, Establishing a Key IP Pillar
-
Endeavour Silver Corp. Announces US$73 Million Bought Deal Financing
-
Mirasol Launches Exploration Season to Advance to Drilling at Sobek Copper-Gold Project in Vicuña District, Chile
